ERBB2 and ductal breast carcinoma in situ: In another study of 1488 DCIS patients, higher TILs correlated with HER2+ phenotype, higher grade, and necrosis, with no impact on ipsilateral DCIS or invasive tumor recurrence, irrespective of the treatment method [56].